Iprazochrome: Difference between revisions
CSV import |
CSV import |
||
| Line 32: | Line 32: | ||
[[Category:Antimigraine drugs]] | [[Category:Antimigraine drugs]] | ||
[[Category:Serotonin receptor antagonists]] | [[Category:Serotonin receptor antagonists]] | ||
==Iprazochrome== | |||
<gallery> | |||
File:Iprazochrome.png|Iprazochrome | |||
</gallery> | |||
Latest revision as of 01:10, 20 February 2025
A drug used in the treatment of migraine and vascular headaches
Iprazochrome is a medication primarily used in the treatment of migraine and other types of vascular headaches. It belongs to the class of drugs known as serotonin receptor antagonists, which work by modulating the effects of serotonin in the brain.
Pharmacology[edit]
Iprazochrome is a derivative of ergot alkaloids, which are compounds derived from the Claviceps purpurea fungus. These compounds have a long history of use in the treatment of headaches due to their ability to constrict blood vessels and alter neurotransmitter activity.
Mechanism of Action[edit]
Iprazochrome acts as a serotonin receptor antagonist, specifically targeting the 5-HT2 receptors. By blocking these receptors, iprazochrome helps to prevent the excessive dilation of blood vessels in the brain, which is a common cause of migraine headaches.
Clinical Use[edit]
Iprazochrome is used in the prophylactic treatment of migraine headaches. It is not effective for the acute treatment of migraine attacks but is used to reduce the frequency and severity of these episodes.
Side Effects[edit]
Common side effects of iprazochrome include nausea, dizziness, and fatigue. In rare cases, it may cause more serious side effects such as allergic reactions or cardiovascular issues.
History[edit]
Iprazochrome was developed in the mid-20th century as part of efforts to find effective treatments for migraine headaches. Its development was based on the understanding of the role of serotonin in migraine pathophysiology.
Related pages[edit]
Iprazochrome[edit]
-
Iprazochrome
